Atlas Trials

Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19

Clinical trial NCT04354259 · COMPLETED

Trial details

NCT number
NCT04354259
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sars-CoV2Covid-19
Start date
2020-05-13
Primary completion
2022-08-19
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.